Showing results (831-840 of 1,021) with videos related to

Sort By:
Pageof 103
Evidence-Based Complementary and Alternative Medicine : Ecam|January 25, 2013
Building a strategic framework for comparative effectiveness research in complementary and integrative medicineClaudia M Witt, Margaret Chesney, Richard Gliklich, et al.
The American Journal of Surgical Pathology|May 18, 2023
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical UtilityJoshua I Warrick, Hikmat Al-Ahmadie, David M Berman, et al.
Acta Crystallographica. Section D, Structural Biology|December 6, 2021
New system for archiving integrative structuresBrinda Vallat, Benjamin Webb, Maryam Fayazi, et al.
Neuropsychiatric Disease and Treatment|June 10, 2011
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorderRobert M Berman, Michael E Thase, Madhukar H Trivedi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancerA D Van den Abbeele, R F Tutrone, R M Berman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 13, 2009
Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffoldD M Berman, J J O'Neil, L C K Coffey, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 20, 2019
In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and PotencyRose M Berman, Olivia J Kelada, Nicholas T Gutsche, et al.
CNS Spectrums|March 20, 2014
Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapyJ Craig Nelson, Zia Rahman, Kimberly K Laubmeier, et al.
The Journal of Clinical Psychiatry|July 9, 2008
A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapineJohn W Newcomer, Joao Alberto Campos, Ronald N Marcus, et al.
Sexually Transmitted Diseases|April 18, 2008
Incidence of neonatal herpes simplex virus infections in two managed care organizations: implications for surveillanceFujie Xu, Julianne M Gee, Allison Naleway, et al.
Pageof 103